EBO vs NSB

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EBO

EBOS FPO NZ [EBO]

50MEDIUM

NSB

NEUROSCIEN FPO [NSB]

50MEDIUM

Score Breakdown

EBO NSB
Technical
74
59
Catalyst
66
50
Sentiment
50
50
Fundamental
100
70
Momentum
39
80
Risk Gate
50
46

Key Metrics

EBO Metric NSB
$3.9BMarket Cap$28.9M
254KAvg Volume (20d)221K
+0.5%Short InterestN/A
$38.23052-Week High$0.260
$17.78052-Week Low$0.034
+0.6%Daily Change+6.1%
$18.890Entry Price$0.087
+9.0%ROE-29.6%
+1.8%Profit MarginN/A

Active Signals

EBO Signals

●MACD momentum is picking up steam
●Volume surging at 4.5x normal while price climbs — real buying conviction behind this move
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.3x)
●Moderate revenue growth (+13%)
●Piotroski F-Score strong (8/9, low-confidence approx)

NSB Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Trading below both moving averages — the trend is working against this one
●On a tear — up 11.5% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Volatility is expanding fast — choppy price action, so buckle up
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (18 quarters)

Ask Scout AI to compare EBO and NSB in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EBO Full Analysis → NSB Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).